Study Shows Promise of Personalized Medicine to Predict Opioid Addiction Risk
Study findings suggest that a validated tool to help prevent opioid abuse has the potential to affect the nation’s growing opioid epidemic.
Read MorePosted by Elaine Sanchez Wilson | Oct 3, 2017 | Research |
Study findings suggest that a validated tool to help prevent opioid abuse has the potential to affect the nation’s growing opioid epidemic.
Read MorePosted by Elaine Sanchez Wilson | Oct 3, 2017 | Cancer, Research |
Cambridge Epigenetix and NuGen Technologies have entered into a partnership to integrate the TrueMethyl technology for oxidative bisulfite sequencing with NuGen’s next-generation sequencing library preparation kits.
Read MorePosted by Elaine Sanchez Wilson | Sep 12, 2017 | Heart Disease, Prenatal Testing, Research |
A large clinical experience study has evaluated the performance of the Panorama noninvasive prenatal test from Natera Inc.
Read MorePosted by Elaine Sanchez Wilson | Sep 5, 2017 | Research |
Translational Software has completed a large-scale analysis of the medication lists of 505,000 patients to identify potentially harmful drug-gene interactions.
Read MorePosted by Elaine Sanchez Wilson | Aug 11, 2017 | Cancer, Molecular Diagnostics |
A novel partnership takes aim at developing NGS companion diagnostics in oncology.
Read More